Yokoyama Ikuo, Inoue Yusuke, Moritan Toshiyuki, Ohtomo Kuni, Nagai Ryozo
Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
J Nucl Med. 2003 Oct;44(10):1592-8.
Skeletal muscle glucose utilization (SMGU) can be measured by dynamic PET imaging with (18)F-FDG to characterize insulin resistance. The aim of this study was to determine the validity of simple methods to quantify SMGU by static PET imaging.
Ten patients underwent dynamic (18)F-FDG PET of the femoral region during hyperinsulinemic euglycemic clamping. SMGU was determined by Patlak graphical analysis using data from dynamic imaging with frequent arterial blood sampling. Standardized uptake values (SUVs) were calculated at 45 and 55 min after tracer injection. Skeletal muscle-to-background ratio (SM/B ratio), tissue count divided by venous plasma activity, was also computed at 45 and 55 min. These simple indices were compared by linear regression with the SMGU measured as above, and an estimated SMGU was obtained using the regression equation thus generated, together with a simple index.
SMGU was highly correlated with SUVs (r = 0.941 at 45 min, r = 0.951 at 55 min) and SM/B ratios (r = 0.968 at 45 min, r = 0.984 at 55 min). Although SMGU was almost proportional to SM/B ratios, the y-intercepts of the regression lines for SUVs significantly differed from zero. The residual in estimating SMGU using the regression equation was marginally smaller for SM/B ratios than for SUVs and for indices at 55 min than at 45 min, but these differences did not reach statistical significance. Correction for plasma glucose level slightly elevated the correlation coefficients between SMGU and these simple indices.
It is proposed that the simple quantitative indices, SUV and the SM/B ratio, are reliable indicators of SMGU during hyperinsulinemic euglycemic clamping. Static imaging with or without a single venous blood sampling may therefore be able to replace dynamic imaging with frequent arterial blood sampling, offering substantially greater convenience in evaluating insulin resistance.
骨骼肌葡萄糖利用率(SMGU)可通过动态PET成像结合(18)F-FDG来测量,以表征胰岛素抵抗。本研究的目的是确定通过静态PET成像量化SMGU的简单方法的有效性。
10例患者在高胰岛素正常血糖钳夹期间接受了股骨区域的动态(18)F-FDG PET检查。通过Patlak图形分析,利用动态成像及频繁动脉血采样的数据来确定SMGU。在注射示踪剂后45分钟和55分钟计算标准化摄取值(SUV)。还在45分钟和55分钟计算骨骼肌与本底比值(SM/B比值),即组织计数除以静脉血浆活性。将这些简单指标与上述测量的SMGU进行线性回归比较,并使用由此生成的回归方程以及一个简单指标获得估计的SMGU。
SMGU与SUV(45分钟时r = 0.941,55分钟时r = 0.951)和SM/B比值(45分钟时r = 0.968,55分钟时r = 0.984)高度相关。尽管SMGU几乎与SM/B比值成正比,但SUV回归线的y轴截距显著不同于零。使用回归方程估计SMGU时,SM/B比值的残差略小于SUV,且55分钟时指标的残差小于45分钟时的,但这些差异未达到统计学显著性。对血浆葡萄糖水平进行校正后,SMGU与这些简单指标之间的相关系数略有升高。
建议简单定量指标SUV和SM/B比值是高胰岛素正常血糖钳夹期间SMGU的可靠指标。因此,无论有无单次静脉血采样的静态成像可能能够替代频繁动脉血采样的动态成像,在评估胰岛素抵抗方面提供更大的便利。